We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Report: Federal 340B Program Needs More Audits, Transparency
Report: Federal 340B Program Needs More Audits, Transparency
July 19, 2013
Not one audit of a pharmaceutical manufacturer has been conducted as part of the government-run discount drug program 340B, an industry stakeholder complained July 9, saying the program saves taxpayers money but should be more transparent.